OCCUDO QUANTITATIVE STRATEGIES LP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.

Quarter-by-quarter ownership
OCCUDO QUANTITATIVE STRATEGIES LP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2022$890,000
-9.7%
22,149
-18.8%
0.07%
-41.5%
Q3 2021$986,000
-66.6%
27,284
-62.1%
0.12%
-73.8%
Q2 2021$2,948,000
+86.8%
71,925
+98.8%
0.45%
+30.7%
Q1 2021$1,578,000
+280.2%
36,173
+336.7%
0.34%
+165.4%
Q4 2020$415,0008,2830.13%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$244,378,00079.54%
Vantage Consulting Group Inc 7,862,542$284,152,00060.85%
Memorial Sloan Kettering Cancer Center 2,680,644$96,878,00060.36%
Indie Asset Partners, LLC 701,323$25,346,00020.53%
HARVARD MANAGEMENT CO INC 7,142,856$258,143,00015.13%
Bleichroeder LP 1,115,980$40,332,0006.55%
Overbrook Management Corp 785,132$28,375,0006.16%
Geo Capital Gestora de Recursos Ltd 194,305$7,022,0003.21%
Brown University 621,759$22,470,0003.05%
Graypoint LLC 610,584$22,067,0002.71%
View complete list of ROYALTY PHARMA PLC shareholders